Clinical trial
Study of Anti-inflammatory Treatment With Colchicine in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery to Reduce Reperfusion Damage
NCT02122484 is registered in ClinicalTrials.gov with G.Gennimatas General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Anti-inflammatory Treatment With Colchicine in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery to Reduce Reperfusion Damage
- Lead sponsor
- G.Gennimatas General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- November 30, 2014
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
elective coronary artery bypass graft surgery